规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
---|---|---|---|---|---|---|---|---|---|
50mg | ¥ ƁōŜƇǪǪ | > 0 | -- | -- | -- | -- | -- | ¥ ƁōŜƇǪǪ | - + |
00mg | ¥ ȄƁƁƇǪǪ | > 0 | -- | -- | -- | -- | -- | ¥ ȄƁƁƇǪǪ | - + |
250mg | ¥ NJòǪƇǪǪ | > 0 | -- | -- | -- | -- | -- | ¥ NJòǪƇǪǪ | - + |
g | ¥ ŜòƒŜƇǪǪ | > 0 | -- | -- | -- | -- | -- | ¥ ŜòƒŜƇǪǪ | - + |
5g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
0g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
25g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
6.8
[]. Joto N, et al. DX-85f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-8-resistant variant. Int J Cancer. 7 Aug 7;72(4):680-6.
[2]. Mitsui I, et al. A new water-soluble camptothecin derivative, DX-85f, exhibits potent antitumor activity against human tumors in vitro and in vivo. Jpn J Cancer Res. 5 Aug;86(8):776-82.
[]. Sun FX, et al. Efficacy of camptothecin analog DX-85f (Exatecan Mesylate) on human pancreatic cancer in an orthotopic metastatic model. Cancer Res. 200 Jan ;6():80-5.
H00-H40-H60
P264-P270-P280-P0-P405-P50
6.
28